News

Back to All News

An injured jellyfish can clone itself and potentially produce hundreds of offspring

MS Society Annual Lecture By Timothy Davies

ms-society

Real Science, along with our Publicis Health UK colleagues, have partnered with the MS Society in a 3 year collaboration which sees us provide both pro bono support to the charity as well as participating in fantastic fundraising activities.
Multiple sclerosis is a fascinating yet debilitating disease, and one we are proud to be involved with; we know that our fundraising efforts go straight to supporting research funded by the MS Society.
Today marks World MS Day, and earlier this month the team at Real Science, plus some colleagues from our sister agencies Publicis LifeBrands and Publicis Resolute and members of the other agencies at Publicis health, attended the annual MS Society Annual Lecture at the Royal College of Physicians. It was great to learn a bit more about the groundbreaking research currently ongoing in the field of progressive MS.
The lecture, titled: ‘Drug Development for Progressive MS: How close are we to success’, featured a presentation by Richard Reynolds, Professor of Cellular Neurobiology at Imperial College London, and Scientific Director of the MS Society tissue bank. He discussed the work that his group is doing to understand the molecular underpinnings of MS, and how his group began by studying the brain tissue of patients with MS, and looking into the differences in those who had progressed more rapidly.
Their discoveries have now formed the basis for a drug that is due for human trials, a huge and exciting achievement!
The lecture was a fascinating insight into how research in the lab can translate into therapies that have the potential to change the lives of people who suffer from debilitating diseases, such as MS.
Professor Reynolds also offered an optimistic outlook for sufferers of late stage, or progressive, MS. There are more treatments in clinical trials than ever before, and at least some of these should make it on to the market for patients.
The evening also featured a speech from Asana Greenstreet, who discussed how, with the help of her support network and drugs to tackle her relapsing and remitting MS, she has remained incredibly active, taking part in a number of long distance runs among other sporting achievements.
The final part of the evening was a panel discussion including Professor Reynolds and a number of distinguished researchers and clinicians in the field of MS and neurodegenerative diseases. The panel fielded questions from the audience and, in keeping with the other talks of the evening, conveyed a sense of tremendous optimism for patients with MS about the future treatments, thanks in part to the tremendous amount of money raised by the STOP MS appeal.
We are delighted to be collaborating with such a deserving charity, and to be helping support groups at the forefront of research.